Logo image of BAT.CA

BATERO GOLD CORP (BAT.CA) Stock Fundamental Analysis

Canada - TSX-V:BAT - CA0705051021 - Common Stock

0.06 CAD
-0.01 (-7.69%)
Last: 8/6/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, BAT scores 1 out of 10 in our fundamental rating. BAT was compared to 810 industry peers in the Metals & Mining industry. BAT has a bad profitability rating. Also its financial health evaluation is rather negative. BAT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BAT has reported negative net income.
In the past year BAT has reported a negative cash flow from operations.
In the past 5 years BAT always reported negative net income.
In the past 5 years BAT always reported negative operating cash flow.
BAT.CA Yearly Net Income VS EBIT VS OCF VS FCFBAT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M

1.2 Ratios

BAT has a Return On Assets of -0.85%. This is amongst the best in the industry. BAT outperforms 82.37% of its industry peers.
With an excellent Return On Equity value of -0.88%, BAT belongs to the best of the industry, outperforming 83.38% of the companies in the same industry.
Industry RankSector Rank
ROA -0.85%
ROE -0.88%
ROIC N/A
ROA(3y)-0.85%
ROA(5y)-1.09%
ROE(3y)-0.86%
ROE(5y)-1.1%
ROIC(3y)N/A
ROIC(5y)N/A
BAT.CA Yearly ROA, ROE, ROICBAT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BAT.CA Yearly Profit, Operating, Gross MarginsBAT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, BAT has about the same amount of shares outstanding.
BAT has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for BAT is higher compared to a year ago.
BAT.CA Yearly Shares OutstandingBAT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BAT.CA Yearly Total Debt VS Total AssetsBAT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

BAT has an Altman-Z score of 1.73. This is a bad value and indicates that BAT is not financially healthy and even has some risk of bankruptcy.
BAT has a Altman-Z score of 1.73. This is comparable to the rest of the industry: BAT outperforms 50.50% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that BAT is not too dependend on debt financing.
BAT has a Debt to Equity ratio (0.03) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 1.73
ROIC/WACCN/A
WACCN/A
BAT.CA Yearly LT Debt VS Equity VS FCFBAT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

BAT has a Current Ratio of 0.22. This is a bad value and indicates that BAT is not financially healthy enough and could expect problems in meeting its short term obligations.
BAT's Current ratio of 0.22 is on the low side compared to the rest of the industry. BAT is outperformed by 77.33% of its industry peers.
A Quick Ratio of 0.22 indicates that BAT may have some problems paying its short term obligations.
BAT has a worse Quick ratio (0.22) than 76.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
BAT.CA Yearly Current Assets VS Current LiabilitesBAT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.00% over the past year.
EPS 1Y (TTM)10%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
BAT.CA Price Earnings VS Forward Price EarningsBAT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BAT.CA Per share dataBAT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BAT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BATERO GOLD CORP

TSX-V:BAT (8/6/2025, 7:00:00 PM)

0.06

-0.01 (-7.69%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)02-04 2022-02-04
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners31.85%
Ins Owner ChangeN/A
Market Cap6.91M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.15
P/tB 0.15
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.41
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.85%
ROE -0.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.85%
ROA(5y)-1.09%
ROE(3y)-0.86%
ROE(5y)-1.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2562.63%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z 1.73
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2735.81%
Cap/Depr(5y)4662.42%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.31%
OCF growth 3YN/A
OCF growth 5YN/A